The Ready-to-use Therapeutic Food and Supplementary Food (RUTF and RUSF) Market Size is estimated to register 8.8% growth over the forecast period from 2023 to 2030.
The persistently high prevalence of malnutrition, especially among children in low-income countries is leading to continued demand and efforts to produce and distribute RUTF and RUSF to combat severe acute malnutrition (SAM) and moderate acute malnutrition (MAM). The pursuit of better nutritional profiles, improved taste, and enhanced stability are increasing the efficacy and acceptance of these therapeutic foods. Further, heightened awareness among policymakers, healthcare professionals, and the public about the severe consequences of malnutrition are driving advocacy efforts. Humanitarian emergencies, including conflicts, natural disasters, and pandemics, are leading to increased demand for RUTF and RUSF in providing immediate nutrition to affected populations, driving market growth during crises. Efforts to source raw materials responsibly and reduce environmental impact are gaining traction.
Studies providing compelling evidence regarding the products' ability to aid in weight gain, improve nutritional status, and reduce mortality rates among malnourished individuals are the key factors.
The success stories and visible outcomes in treating malnutrition with RUTF and RUSF are garnering wider attention and acceptance among healthcare professionals, policymakers, and aid organizations.
Additionally, their ready-to-use nature eliminates the need for additional preparation, making them highly suitable for use in remote or under-resourced areas where access to cooking facilities or clean water might be limited is highly increasing the market growth.
Persistent economic challenges, poverty, food insecurity, and limited access to nutritious food sources in many regions are contributing to the widespread of the market to prevent malnutrition.Additionally, humanitarian crises, natural disasters, armed conflicts, and climate-related disruptions exacerbate food shortages leading to displacement, disruption of food supplies, and compromised access to healthcare are increasing the demand.The tangible results in treating malnutrition, such as swift recovery, improved health outcomes, and reduced hospitalization, are reinforcing the credibility and efficacy of these therapeutic foods.
Increasing recognition of the role RUTF and RUSF in managing chronic illnesses or conditions requiring specialized nutritional support are fueling the market growth.Further, studies showing promising results in using these products to support maternal health, aiding in the nutritional requirements of pregnant and lactating women to improve birth outcomes and infant health are contributing top its widespread.Additionally, efforts are being made to tailor these products to provide targeted nutrition, focusing on micronutrient supplementation and addressing deficiencies prevalent in different population segments or specific health conditions.
The Ready-to-use Therapeutic Food and Supplementary Food (RUTF and RUSF) Market is analyzed across Ready-to-use Therapeutic Food (RUTF) & Ready-to-use Supplementary Food (RUSF). Ready-to-use Therapeutic Food (RUTF) is poised to register the fastest growth. RUTF is specifically designed to treat severe acute malnutrition (SAM) and has gained significant attention and investment due to its high effectiveness in combating malnutrition, particularly among children. They are formulated with a high concentration of nutrients, including energy, protein, vitamins, and minerals, packed into a ready-to-use paste or bar. These products have been widely adopted in nutrition intervention programs, especially in developing countries and regions facing malnutrition challenges, contributing to the segment's rapid growth. One of the defining features of RUTF is its immediate usability without the need for further preparation, cooking, or access to clean water, making it a practical solution, especially in resource-limited and emergency settings. The formulation not only aims to promote weight gain but also supports immune function, aiding in overall recovery and improved health outcomes.
The Ready-to-use Therapeutic Food and Supplementary Food (RUTF and RUSF) Market is analyzed across various Organizations including United Nations Agencies, Charities, Hospitals, Dispensaries & NGOs. Of these, Non-Governmental Organizations (NGOs) held a significant market share in 2023. NGOs are pivotal in several aspects of the RUTF and RUSF market. They actively engage in raising awareness about malnutrition-related issues, mobilizing resources, and collaborating with governments, international agencies, and local communities to execute and sustain nutrition intervention programs. Their on-ground presence and understanding of local contexts enable them to tailor interventions to meet specific regional needs effectively. Further, they often lead the distribution and implementation of RUTF and RUSF, ensuring these therapeutic foods reach the targeted beneficiaries. They work towards creating and maintaining reliable supply chains, overcoming logistical challenges, and establishing distribution networks in remote or underserved areas to ensure timely and equitable access to these life-saving interventions.
By Type
By Industry
By Distribution Channel
By Region
*List not exhaustive
Ready-to-use Therapeutic Food and Supplementary Food Market Outlook 2023
1 Market Overview
1.1 Introduction to the Ready-to-use Therapeutic Food and Supplementary Food Market
1.2 Scope of the Study
1.3 Research Objective
1.3.1 Key Market Scope and Segments
1.3.2 Players Covered
1.3.3 Years Considered
2 Executive Summary
2.1 2023 Ready-to-use Therapeutic Food and Supplementary Food Industry- Market Statistics
3 Market Dynamics
3.1 Market Drivers
3.2 Market Challenges
3.3 Market Opportunities
3.4 Market Trends
4 Market Factor Analysis
4.1 Porter’s Five Forces
4.2 Market Entropy
4.2.1 Global Ready-to-use Therapeutic Food and Supplementary Food Market Companies with Area Served
4.2.2 Products Offerings Global Ready-to-use Therapeutic Food and Supplementary Food Market
5 COVID-19 Impact Analysis and Outlook Scenarios
5.1.1 Covid-19 Impact Analysis
5.1.2 post-COVID-19 Scenario- Low Growth Case
5.1.3 post-COVID-19 Scenario- Reference Growth Case
5.1.4 post-COVID-19 Scenario- Low Growth Case
6 Global Ready-to-use Therapeutic Food and Supplementary Food Market Trends
6.1 Global Ready-to-use Therapeutic Food and Supplementary Food Revenue (USD Million) and CAGR (%) by Type (2018-2030)
6.2 Global Ready-to-use Therapeutic Food and Supplementary Food Revenue (USD Million) and CAGR (%) by Applications (2018-2030)
6.3 Global Ready-to-use Therapeutic Food and Supplementary Food Revenue (USD Million) and CAGR (%) by regions (2018-2030)
7 Global Ready-to-use Therapeutic Food and Supplementary Food Market Revenue (USD Million) by Type, and Applications (2018-2022)
7.1 Global Ready-to-use Therapeutic Food and Supplementary Food Revenue (USD Million) by Type (2018-2022)
7.1.1 Global Ready-to-use Therapeutic Food and Supplementary Food Revenue (USD Million), Market Share (%) by Type (2018-2022)
7.2 Global Ready-to-use Therapeutic Food and Supplementary Food Revenue (USD Million) by Applications (2018-2022)
7.2.1 Global Ready-to-use Therapeutic Food and Supplementary Food Revenue (USD Million), Market Share (%) by Applications (2018-2022)
8 Global Ready-to-use Therapeutic Food and Supplementary Food Development Regional Status and Outlook
8.1 Global Ready-to-use Therapeutic Food and Supplementary Food Revenue (USD Million) By Regions (2018-2022)
8.2 North America Ready-to-use Therapeutic Food and Supplementary Food Revenue (USD Million) by Type, and Application (2018-2022)
8.2.1 North America Ready-to-use Therapeutic Food and Supplementary Food Revenue (USD Million) by Country (2018-2022)
8.2.2 North America Ready-to-use Therapeutic Food and Supplementary Food Revenue (USD Million) by Type (2018-2022)
8.2.3 North America Ready-to-use Therapeutic Food and Supplementary Food Revenue (USD Million) by Applications (2018-2022)
8.3 Europe Ready-to-use Therapeutic Food and Supplementary Food Revenue (USD Million), by Type, and Applications (USD Million) (2018-2022)
8.3.1 Europe Ready-to-use Therapeutic Food and Supplementary Food Revenue (USD Million), by Country (2018-2022)
8.3.2 Europe Ready-to-use Therapeutic Food and Supplementary Food Revenue (USD Million) by Type (2018-2022)
8.3.3 Europe Ready-to-use Therapeutic Food and Supplementary Food Revenue (USD Million) by Applications (2018-2022)
8.4 Asia Pacific Ready-to-use Therapeutic Food and Supplementary Food Revenue (USD Million), and Revenue (USD Million) by Type, and Applications (2018-2022)
8.4.1 Asia Pacific Ready-to-use Therapeutic Food and Supplementary Food Revenue (USD Million) by Country (2018-2022)
8.4.2 Asia Pacific Ready-to-use Therapeutic Food and Supplementary Food Revenue (USD Million) by Type (2018-2022)
8.4.3 Asia Pacific Ready-to-use Therapeutic Food and Supplementary Food Revenue (USD Million) by Applications (2018-2022)
8.5 South America Ready-to-use Therapeutic Food and Supplementary Food Revenue (USD Million), by Type, and Applications (2018-2022)
8.5.1 South America Ready-to-use Therapeutic Food and Supplementary Food Revenue (USD Million), by Country (2018-2022)
8.5.2 South America Ready-to-use Therapeutic Food and Supplementary Food Revenue (USD Million) by Type (2018-2022)
8.5.3 South America Ready-to-use Therapeutic Food and Supplementary Food Revenue (USD Million) by Applications (2018-2022)
8.6 Middle East and Africa Ready-to-use Therapeutic Food and Supplementary Food Revenue (USD Million), by Type, Technology, Application, Thickness (2018-2022)
8.6.1 Middle East and Africa Ready-to-use Therapeutic Food and Supplementary Food Revenue (USD Million) by Country (2018-2022)
8.6.2 Middle East and Africa Ready-to-use Therapeutic Food and Supplementary Food Revenue (USD Million) by Type (2018-2022)
8.6.3 Middle East and Africa Ready-to-use Therapeutic Food and Supplementary Food Revenue (USD Million) by Applications (2018-2022)
9 Company Profiles
10 Global Ready-to-use Therapeutic Food and Supplementary Food Market Revenue (USD Million), by Type, and Applications (2023-2030)
10.1 Global Ready-to-use Therapeutic Food and Supplementary Food Revenue (USD Million) and Market Share (%) by Type (2023-2030)
10.1.1 Global Ready-to-use Therapeutic Food and Supplementary Food Revenue (USD Million), and Market Share (%) by Type (2023-2030)
10.2 Global Ready-to-use Therapeutic Food and Supplementary Food Revenue (USD Million) and Market Share (%) by Applications (2023-2030)
10.2.1 Global Ready-to-use Therapeutic Food and Supplementary Food Revenue (USD Million), and Market Share (%) by Applications (2023-2030)
11 Global Ready-to-use Therapeutic Food and Supplementary Food Development Regional Status and Outlook Forecast
11.1 Global Ready-to-use Therapeutic Food and Supplementary Food Revenue (USD Million) By Regions (2023-2030)
11.2 North America Ready-to-use Therapeutic Food and Supplementary Food Revenue (USD Million) by Type, and Applications (2023-2030)
11.2.1 North America Ready-to-use Therapeutic Food and Supplementary Food Revenue (USD) Million by Country (2023-2030)
11.2.2 North America Ready-to-use Therapeutic Food and Supplementary Food Revenue (USD Million), by Type (2023-2030)
11.2.3 North America Ready-to-use Therapeutic Food and Supplementary Food Revenue (USD Million), Market Share (%) by Applications (2023-2030)
11.3 Europe Ready-to-use Therapeutic Food and Supplementary Food Revenue (USD Million), by Type, and Applications (2023-2030)
11.3.1 Europe Ready-to-use Therapeutic Food and Supplementary Food Revenue (USD Million), by Country (2023-2030)
11.3.2 Europe Ready-to-use Therapeutic Food and Supplementary Food Revenue (USD Million), by Type (2023-2030)
11.3.3 Europe Ready-to-use Therapeutic Food and Supplementary Food Revenue (USD Million), by Applications (2023-2030)
11.4 Asia Pacific Ready-to-use Therapeutic Food and Supplementary Food Revenue (USD Million) by Type, and Applications (2023-2030)
11.4.1 Asia Pacific Ready-to-use Therapeutic Food and Supplementary Food Revenue (USD Million), by Country (2023-2030)
11.4.2 Asia Pacific Ready-to-use Therapeutic Food and Supplementary Food Revenue (USD Million), by Type (2023-2030)
11.4.3 Asia Pacific Ready-to-use Therapeutic Food and Supplementary Food Revenue (USD Million), by Applications (2023-2030)
11.5 South America Ready-to-use Therapeutic Food and Supplementary Food Revenue (USD Million), by Type, and Applications (2023-2030)
11.5.1 South America Ready-to-use Therapeutic Food and Supplementary Food Revenue (USD Million), by Country (2023-2030)
11.5.2 South America Ready-to-use Therapeutic Food and Supplementary Food Revenue (USD Million), by Type (2023-2030)
11.5.3 South America Ready-to-use Therapeutic Food and Supplementary Food Revenue (USD Million), by Applications (2023-2030)
11.6 Middle East and Africa Ready-to-use Therapeutic Food and Supplementary Food Revenue (USD Million), by Type, and Applications (2023-2030)
11.6.1 Middle East and Africa Ready-to-use Therapeutic Food and Supplementary Food Revenue (USD Million), by region (2023-2030)
11.6.2 Middle East and Africa Ready-to-use Therapeutic Food and Supplementary Food Revenue (USD Million), by Type (2023-2030)
11.6.3 Middle East and Africa Ready-to-use Therapeutic Food and Supplementary Food Revenue (USD Million), by Applications (2023-2030)
12 Methodology and Data Sources
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Sources
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Disclaimer
List of Tables
Table 1 Market Segmentation Analysis
Table 2 Global Ready-to-use Therapeutic Food and Supplementary Food Market Companies with Areas Served
Table 3 Products Offerings Global Ready-to-use Therapeutic Food and Supplementary Food Market
Table 4 Low Growth Scenario Forecasts
Table 5 Reference Case Growth Scenario
Table 6 High Growth Case Scenario
Table 7 Global Ready-to-use Therapeutic Food and Supplementary Food Revenue (USD Million) And CAGR (%) By Type (2018-2030)
Table 8 Global Ready-to-use Therapeutic Food and Supplementary Food Revenue (USD Million) And CAGR (%) By Applications (2018-2030)
Table 9 Global Ready-to-use Therapeutic Food and Supplementary Food Revenue (USD Million) And CAGR (%) By Regions (2018-2030)
Table 10 Global Ready-to-use Therapeutic Food and Supplementary Food Revenue (USD Million) By Type (2018-2022)
Table 11 Global Ready-to-use Therapeutic Food and Supplementary Food Revenue Market Share (%) By Type (2018-2022)
Table 12 Global Ready-to-use Therapeutic Food and Supplementary Food Revenue (USD Million) By Applications (2018-2022)
Table 13 Global Ready-to-use Therapeutic Food and Supplementary Food Revenue Market Share (%) By Applications (2018-2022)
Table 14 Global Ready-to-use Therapeutic Food and Supplementary Food Market Revenue (USD Million) By Regions (2018-2022)
Table 15 Global Ready-to-use Therapeutic Food and Supplementary Food Market Share (%) By Regions (2018-2022)
Table 16 North America Ready-to-use Therapeutic Food and Supplementary Food Revenue (USD Million) By Country (2018-2022)
Table 17 North America Ready-to-use Therapeutic Food and Supplementary Food Revenue (USD Million) By Type (2018-2022)
Table 18 North America Ready-to-use Therapeutic Food and Supplementary Food Revenue (USD Million) By Applications (2018-2022)
Table 19 Europe Ready-to-use Therapeutic Food and Supplementary Food Revenue (USD Million) By Country (2018-2022)
Table 20 Europe Ready-to-use Therapeutic Food and Supplementary Food Revenue (USD Million) By Type (2018-2022)
Table 21 Europe Ready-to-use Therapeutic Food and Supplementary Food Revenue (USD Million) By Applications (2018-2022)
Table 22 Asia Pacific Ready-to-use Therapeutic Food and Supplementary Food Revenue (USD Million) By Country (2018-2022)
Table 23 Asia Pacific Ready-to-use Therapeutic Food and Supplementary Food Revenue (USD Million) By Type (2018-2022)
Table 24 Asia Pacific Ready-to-use Therapeutic Food and Supplementary Food Revenue (USD Million) By Applications (2018-2022)
Table 25 South America Ready-to-use Therapeutic Food and Supplementary Food Revenue (USD Million) By Country (2018-2022)
Table 26 South America Ready-to-use Therapeutic Food and Supplementary Food Revenue (USD Million) By Type (2018-2022)
Table 27 South America Ready-to-use Therapeutic Food and Supplementary Food Revenue (USD Million) By Applications (2018-2022)
Table 28 Middle East and Africa Ready-to-use Therapeutic Food and Supplementary Food Revenue (USD Million) By Region (2018-2022)
Table 29 Middle East and Africa Ready-to-use Therapeutic Food and Supplementary Food Revenue (USD Million) By Type (2018-2022)
Table 30 Middle East and Africa Ready-to-use Therapeutic Food and Supplementary Food Revenue (USD Million) By Applications (2018-2022)
Table 31 Financial Analysis
Table 32 Global Ready-to-use Therapeutic Food and Supplementary Food Revenue (USD Million) By Type (2023-2030)
Table 33 Global Ready-to-use Therapeutic Food and Supplementary Food Revenue Market Share (%) By Type (2023-2030)
Table 34 Global Ready-to-use Therapeutic Food and Supplementary Food Revenue (USD Million) By Applications (2023-2030)
Table 35 Global Ready-to-use Therapeutic Food and Supplementary Food Revenue Market Share (%) By Applications (2023-2030)
Table 36 Global Ready-to-use Therapeutic Food and Supplementary Food Market Revenue (USD Million), And Revenue (USD Million) By Regions (2023-2030)
Table 37 North America Ready-to-use Therapeutic Food and Supplementary Food Revenue (USD)By Country (2023-2030)
Table 38 North America Ready-to-use Therapeutic Food and Supplementary Food Revenue (USD Million) By Type (2023-2030)
Table 39 North America Ready-to-use Therapeutic Food and Supplementary Food Revenue (USD Million) By Applications (2023-2030)
Table 40 Europe Ready-to-use Therapeutic Food and Supplementary Food Revenue (USD Million) By Country (2023-2030)
Table 41 Europe Ready-to-use Therapeutic Food and Supplementary Food Revenue (USD Million) By Type (2023-2030)
Table 42 Europe Ready-to-use Therapeutic Food and Supplementary Food Revenue (USD Million) By Applications (2023-2030)
Table 43 Asia Pacific Ready-to-use Therapeutic Food and Supplementary Food Revenue (USD Million) By Country (2023-2030)
Table 44 Asia Pacific Ready-to-use Therapeutic Food and Supplementary Food Revenue (USD Million) By Type (2023-2030)
Table 45 Asia Pacific Ready-to-use Therapeutic Food and Supplementary Food Revenue (USD Million) By Applications (2023-2030)
Table 46 South America Ready-to-use Therapeutic Food and Supplementary Food Revenue (USD Million) By Country (2023-2030)
Table 47 South America Ready-to-use Therapeutic Food and Supplementary Food Revenue (USD Million) By Type (2023-2030)
Table 48 South America Ready-to-use Therapeutic Food and Supplementary Food Revenue (USD Million) By Applications (2023-2030)
Table 49 Middle East and Africa Ready-to-use Therapeutic Food and Supplementary Food Revenue (USD Million) By Region (2023-2030)
Table 50 Middle East and Africa Ready-to-use Therapeutic Food and Supplementary Food Revenue (USD Million) By Region (2023-2030)
Table 51 Middle East and Africa Ready-to-use Therapeutic Food and Supplementary Food Revenue (USD Million) By Type (2023-2030)
Table 52 Middle East and Africa Ready-to-use Therapeutic Food and Supplementary Food Revenue (USD Million) By Applications (2023-2030)
Table 53 Research Programs/Design for This Report
Table 54 Key Data Information from Secondary Sources
Table 55 Key Data Information from Primary Sources
List of Figures
Figure 1 Market Scope
Figure 2 Porter’s Five Forces
Figure 3 Global Ready-to-use Therapeutic Food and Supplementary Food Revenue (USD Million) By Type (2018-2022)
Figure 4 Global Ready-to-use Therapeutic Food and Supplementary Food Revenue Market Share (%) By Type (2022)
Figure 5 Global Ready-to-use Therapeutic Food and Supplementary Food Revenue (USD Million) By Applications (2018-2022)
Figure 6 Global Ready-to-use Therapeutic Food and Supplementary Food Revenue Market Share (%) By Applications (2022)
Figure 7 Global Ready-to-use Therapeutic Food and Supplementary Food Market Revenue (USD Million) By Regions (2018-2022)
Figure 8 Global Ready-to-use Therapeutic Food and Supplementary Food Market Share (%) By Regions (2022)
Figure 9 North America Ready-to-use Therapeutic Food and Supplementary Food Revenue (USD Million) By Country (2018-2022)
Figure 10 North America Ready-to-use Therapeutic Food and Supplementary Food Revenue (USD Million) By Type (2018-2022)
Figure 11 North America Ready-to-use Therapeutic Food and Supplementary Food Revenue (USD Million) By Applications (2018-2022)
Figure 12 Europe Ready-to-use Therapeutic Food and Supplementary Food Revenue (USD Million) By Country (2018-2022)
Figure 13 Europe Ready-to-use Therapeutic Food and Supplementary Food Revenue (USD Million) By Type (2018-2022)
Figure 14 Europe Ready-to-use Therapeutic Food and Supplementary Food Revenue (USD Million) By Applications (2018-2022)
Figure 15 Asia Pacific Ready-to-use Therapeutic Food and Supplementary Food Revenue (USD Million) By Country (2018-2022)
Figure 16 Asia Pacific Ready-to-use Therapeutic Food and Supplementary Food Revenue (USD Million) By Type (2018-2022)
Figure 17 Asia Pacific Ready-to-use Therapeutic Food and Supplementary Food Revenue (USD Million) By Applications (2018-2022)
Figure 18 South America Ready-to-use Therapeutic Food and Supplementary Food Revenue (USD Million) By Country (2018-2022)
Figure 19 South America Ready-to-use Therapeutic Food and Supplementary Food Revenue (USD Million) By Type (2018-2022)
Figure 20 South America Ready-to-use Therapeutic Food and Supplementary Food Revenue (USD Million) By Applications (2018-2022)
Figure 21 Middle East and Africa Ready-to-use Therapeutic Food and Supplementary Food Revenue (USD Million) By Region (2018-2022)
Figure 22 Middle East and Africa Ready-to-use Therapeutic Food and Supplementary Food Revenue (USD Million) By Type (2018-2022)
Figure 23 Middle East and Africa Ready-to-use Therapeutic Food and Supplementary Food Revenue (USD Million) By Applications (2018-2022)
Figure 24 Global Ready-to-use Therapeutic Food and Supplementary Food Revenue (USD Million) By Type (2023-2030)
Figure 25 Global Ready-to-use Therapeutic Food and Supplementary Food Revenue Market Share (%) By Type (2030)
Figure 26 Global Ready-to-use Therapeutic Food and Supplementary Food Revenue (USD Million) By Applications (2023-2030)
Figure 27 Global Ready-to-use Therapeutic Food and Supplementary Food Revenue Market Share (%) By Applications (2030)
Figure 28 Global Ready-to-use Therapeutic Food and Supplementary Food Market Revenue (USD Million) By Regions (2023-2030)
Figure 29 North America Ready-to-use Therapeutic Food and Supplementary Food Revenue (USD Million) By Country (2023-2030)
Figure 30 North America Ready-to-use Therapeutic Food and Supplementary Food Revenue (USD Million) By Type (2023-2030)
Figure 31 North America Ready-to-use Therapeutic Food and Supplementary Food Revenue (USD Million) By Applications (2023-2030)
Figure 32 Europe Ready-to-use Therapeutic Food and Supplementary Food Revenue (USD Million) By Country (2023-2030)
Figure 33 Europe Ready-to-use Therapeutic Food and Supplementary Food Revenue (USD Million) By Type (2023-2030)
Figure 34 Europe Ready-to-use Therapeutic Food and Supplementary Food Revenue (USD Million) By Applications (2023-2030)
Figure 35 Asia Pacific Ready-to-use Therapeutic Food and Supplementary Food Revenue (USD Million) By Country (2023-2030)
Figure 36 Asia Pacific Ready-to-use Therapeutic Food and Supplementary Food Revenue (USD Million) By Type (2023-2030)
Figure 37 Asia Pacific Ready-to-use Therapeutic Food and Supplementary Food Revenue (USD Million) By Applications (2023-2030)
Figure 38 South America Ready-to-use Therapeutic Food and Supplementary Food Revenue (USD Million) By Country (2023-2030)
Figure 39 South America Ready-to-use Therapeutic Food and Supplementary Food Revenue (USD Million) By Type (2023-2030)
Figure 40 South America Ready-to-use Therapeutic Food and Supplementary Food Revenue (USD Million) By Applications (2023-2030)
Figure 41 Middle East and Africa Ready-to-use Therapeutic Food and Supplementary Food Revenue (USD Million) By Region (2023-2030)
Figure 42 Middle East and Africa Ready-to-use Therapeutic Food and Supplementary Food Revenue (USD Million) By Region (2023-2030)
Figure 43 Middle East and Africa Ready-to-use Therapeutic Food and Supplementary Food Revenue (USD Million) By Type (2023-2030)
Figure 44 Middle East and Africa Ready-to-use Therapeutic Food and Supplementary Food Revenue (USD Million) By Applications (2023-2030)
Figure 45 Bottom-Up and Top-Down Approaches for This Report
Figure 46 Data Triangulation
By Type
By Industry
By Distribution Channel
By Region